YANTAC TABLET

Price 1900 INR/ Box

Get a Price/Quote

MOQ : 500 Boxes

YANTAC TABLET Specification

Drug Type
General Medicines

Ingredients
RANITIDINE HYDROCHALORIDE 150 MG

Physical Form
Tablets

Function
Antibiotic Medicine

Recommended For
DIATERY SUPPLEMENT

Dosage
TWICE A DAY

Dosage Guidelines
TWICE A DAY

Suitable For
Suitable For All

Quantity
500 Boxes

Storage Instructions
BELOW 25 DEGREE CALSIS

YANTAC TABLET Trade Information

Minimum Order Quantity
500 Boxes

FOB Port
SONIPAT

Payment Terms
Cash in Advance (CID)

Delivery Time
30 Days

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
20*2*15 STRIP

Main Export Market(s)
Asia, Australia, South America, Eastern Europe, Central America, North America, Western Europe, Middle East, Africa

Main Domestic Market
All India

Certifications
WHO-GMP , ISO , FSSAI , HALAL

About YANTAC TABLET

YANTAC TABLET is a resplendent antibiotic medicine, formulated with Ranitidine Hydrochloride 150 mg, to provide formidable support for dietary supplementation. Designed for suitability for all demographics, its ineffable quality ensures optimal performance. With great in-demand distribution across various sectors in India, YANTAC Tablet is selected for its efficacy and reliability. It comes in tablet form and is packaged under stringent conditions to maintain below 25C Celsius. Dosage guidelines suggest twice-a-day consumption, offering seamless integration into daily regimen.

YANTAC TABLET: Application and Advantage

YANTAC TABLET is the ineffable dietary supplement choice for its impactful qualities, suitable for antibiotic usage essential for human functional health. Its application media spans healthcare and pharmaceutical environments, marking it invaluable for maintaining nutritional needs.

YANTAC TABLET: Order and Supply

YANTAC TABLET ensures order completion and dispatch within efficient timelines. With a substantial supply ability and expertly designed packaging, the product is distributed through FOB ports and samples are available for evaluation by interested parties.